Is Incyte Corporation (INCY) a Buy, Sell, or Hold?
Incyte Corporation
NASDAQ:INCY
$115.09 USD
$0.21 (0.18%)
- Volume
- 1.51M
- Average Volume
- 1.73M
- Market Capitalization
- $22.99B
- P/E Ratio
- 15.77
- Dividend Yield
- 0.00%
- Price Target
- $108.50
- Year High
- $118.97
- Year Low
- $67.17
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.68
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
113
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
107
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$740.52K
INCY Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
INCY Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Mayes Patrick A | officer: EVP & Chief Scientific Officer | 2026-07-02 | F-InKind | 116.86 | 2026-07-07 |
| Tray Thomas | officer: Principal Accounting Officer | 2026-07-02 | F-InKind | 116.86 | 2026-07-07 |
| Meury William | director, officer, other: Chief Executive Officer | 2026-07-02 | F-InKind | 116.86 | 2026-07-07 |
| Stein Steven H | officer: CMO & Head of Late-Stage Dev. | 2026-07-02 | F-InKind | 116.86 | 2026-07-07 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-06-30 | A-Award | 0 | 2026-07-02 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-06-30 | A-Award | 0 | 2026-07-02 |
| Clancy Paul J | director | 2026-06-30 | A-Award | 113.36 | 2026-07-02 |
| HARRIGAN EDMUND | director | 2026-06-30 | A-Award | 113.36 | 2026-07-02 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-06-08 | A-Award | 0 | 2026-06-10 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-06-08 | A-Award | 0 | 2026-06-10 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-06-08 | A-Award | 100.64 | 2026-06-10 |
| HARRIGAN EDMUND | director | 2026-06-08 | A-Award | 0 | 2026-06-10 |
| HARRIGAN EDMUND | director | 2026-06-08 | A-Award | 100.64 | 2026-06-10 |
| Clancy Paul J | director | 2026-06-08 | A-Award | 0 | 2026-06-10 |
| Clancy Paul J | director | 2026-06-08 | A-Award | 100.64 | 2026-06-10 |
| FOUSE JACQUALYN A | director | 2026-06-08 | A-Award | 0 | 2026-06-10 |
| FOUSE JACQUALYN A | director | 2026-06-08 | A-Award | 100.64 | 2026-06-10 |
| BIENAIME JEAN JACQUES | director | 2026-06-08 | A-Award | 0 | 2026-06-10 |
| BIENAIME JEAN JACQUES | director | 2026-06-08 | A-Award | 100.64 | 2026-06-10 |
| High Katherine A | director | 2026-06-08 | A-Award | 0 | 2026-06-10 |
| High Katherine A | director | 2026-06-08 | A-Award | 100.64 | 2026-06-10 |
| BRAWLEY OTIS W | director | 2026-06-08 | A-Award | 0 | 2026-06-10 |
| BRAWLEY OTIS W | director | 2026-06-08 | A-Award | 100.64 | 2026-06-10 |
| Tray Thomas | officer: Principal Accounting Officer | 2026-06-04 | M-Exempt | 83.83 | 2026-06-08 |
| Tray Thomas | officer: Principal Accounting Officer | 2026-06-04 | S-Sale | 100 | 2026-06-08 |
| Tray Thomas | officer: Principal Accounting Officer | 2026-06-04 | M-Exempt | 83.83 | 2026-06-08 |
| Tray Thomas | officer: Principal Accounting Officer | 2026-05-26 | S-Sale | 97.35 | 2026-05-28 |
| BIENAIME JEAN JACQUES | director | 2026-05-26 | M-Exempt | 84.53 | 2026-05-28 |
| BIENAIME JEAN JACQUES | director | 2026-05-26 | F-InKind | 97.1 | 2026-05-28 |
| BIENAIME JEAN JACQUES | director | 2026-05-26 | M-Exempt | 84.53 | 2026-05-28 |
| Clancy Paul J | director | 2026-05-19 | M-Exempt | 84.53 | 2026-05-21 |
| Clancy Paul J | director | 2026-05-19 | S-Sale | 94.93 | 2026-05-21 |
| Clancy Paul J | director | 2026-05-19 | M-Exempt | 84.53 | 2026-05-21 |
| Stein Steven H | officer: CMO & Head of Late-Stage Dev. | 2026-05-06 | A-Award | 0 | 2026-05-20 |
| CAGNONI PABLO J | officer: President, Global Head of R&D | 2026-05-06 | A-Award | 0 | 2026-05-20 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-05-08 | M-Exempt | 84.53 | 2026-05-11 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-05-08 | M-Exempt | 84.53 | 2026-05-11 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-05-08 | M-Exempt | 84.53 | 2026-05-11 |
| Upadhyay Suketu | officer: EVP & Chief Financial Officer | 2026-05-04 | A-Award | 97.14 | 2026-05-06 |
| Upadhyay Suketu | officer: EVP & Chief Financial Officer | 2026-05-04 | A-Award | 0 | 2026-05-06 |
| Upadhyay Suketu | officer: EVP & Chief Financial Officer | 2026-05-04 | A-Award | 0 | 2026-05-06 |
| Upadhyay Suketu | officer | 2026-05-04 | 0 | 2026-05-06 | |
| CAGNONI PABLO J | officer: President, Global Head of R&D | 2026-04-17 | M-Exempt | 71.93 | 2026-04-21 |
| CAGNONI PABLO J | officer: President, Global Head of R&D | 2026-04-17 | M-Exempt | 64.25 | 2026-04-21 |
| CAGNONI PABLO J | officer: President, Global Head of R&D | 2026-04-17 | S-Sale | 96.5 | 2026-04-21 |
| CAGNONI PABLO J | officer: President, Global Head of R&D | 2026-04-17 | M-Exempt | 71.93 | 2026-04-21 |
| CAGNONI PABLO J | officer: President, Global Head of R&D | 2026-04-17 | M-Exempt | 64.25 | 2026-04-21 |
| Meury William | director, officer, other: Chief Executive Officer | 2026-04-15 | M-Exempt | 0 | 2026-04-17 |
| CAGNONI PABLO J | officer: President, Global Head of R&D | 2026-04-15 | A-Award | 0 | 2026-04-17 |
| Stein Steven H | officer: CMO & Head of Late-Stage Dev. | 2026-04-15 | A-Award | 0 | 2026-04-17 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-03-31 | A-Award | 0 | 2026-04-02 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2026-03-31 | A-Award | 0 | 2026-04-02 |
| HARRIGAN EDMUND | director | 2026-03-31 | A-Award | 94.12 | 2026-04-02 |
| Clancy Paul J | director | 2026-03-31 | A-Award | 94.12 | 2026-04-02 |
| Trotta Matteo | officer: EVP, GM, Dermatology US | 2026-03-25 | F-InKind | 92.23 | 2026-03-26 |
| CAGNONI PABLO J | officer: President, R&D | 2026-03-17 | M-Exempt | 64.25 | 2026-03-19 |
| CAGNONI PABLO J | officer: President, R&D | 2026-03-17 | M-Exempt | 61.18 | 2026-03-19 |
| CAGNONI PABLO J | officer: President, R&D | 2026-03-17 | S-Sale | 94.24 | 2026-03-19 |
| CAGNONI PABLO J | officer: President, R&D | 2026-03-17 | M-Exempt | 64.25 | 2026-03-19 |
| CAGNONI PABLO J | officer: President, R&D | 2026-03-17 | M-Exempt | 61.18 | 2026-03-19 |
| CAGNONI PABLO J | officer: President, R&D | 2026-02-19 | M-Exempt | 61.18 | 2026-02-23 |
| CAGNONI PABLO J | officer: President, R&D | 2026-02-19 | M-Exempt | 61.76 | 2026-02-23 |
| CAGNONI PABLO J | officer: President, R&D | 2026-02-19 | S-Sale | 100.91 | 2026-02-23 |
| CAGNONI PABLO J | officer: President, R&D | 2026-02-19 | M-Exempt | 61.18 | 2026-02-23 |
| CAGNONI PABLO J | officer: President, R&D | 2026-02-19 | M-Exempt | 61.76 | 2026-02-23 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | 2026-02-02 | F-InKind | 102.67 | 2026-02-04 |
| Heeson Lee | officer: EVP, Head of Incyte Intl | 2026-02-02 | F-InKind | 102.67 | 2026-02-04 |
| Heeson Lee | officer: EVP, Head of Incyte Intl | 2026-01-16 | A-Award | 0 | 2026-01-21 |
| CAGNONI PABLO J | officer: President, R&D | 2026-01-16 | A-Award | 106.21 | 2026-01-21 |
| Stein Steven H | officer: EVP & Chief Medical Officer | 2026-01-16 | A-Award | 106.21 | 2026-01-21 |
| Issa Mohamed Khairie | officer: EVP, Head of US Oncology | 2026-01-16 | A-Award | 106.21 | 2026-01-21 |
| Trotta Matteo | officer: EVP, GM, Dermatology US | 2026-01-16 | A-Award | 106.21 | 2026-01-21 |
| Tray Thomas | officer: Principal Accounting Officer | 2026-01-16 | A-Award | 106.21 | 2026-01-21 |
| Mayes Patrick A | officer: EVP & Chief Scientific Officer | 2026-01-16 | A-Award | 106.21 | 2026-01-21 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | 2026-01-16 | A-Award | 0 | 2026-01-21 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | 2026-01-20 | F-InKind | 102.62 | 2026-01-21 |
| Issa Mohamed Khairie | officer: EVP, Head of US Oncology | 2026-01-06 | F-InKind | 106.66 | 2026-01-08 |
| Issa Mohamed Khairie | officer: EVP, Head of US Oncology | 2026-01-07 | S-Sale | 109.07 | 2026-01-08 |
| Stein Steven H | officer: EVP & Chief Medical Officer | 2026-01-05 | S-Sale | 101.7 | 2026-01-07 |
| Clancy Paul J | director | 2025-12-31 | A-Award | 98.77 | 2026-01-05 |
| HARRIGAN EDMUND | director | 2025-12-31 | A-Award | 98.77 | 2026-01-05 |
| Stein Steven H | officer: EVP & Chief Medical Officer | 2025-12-31 | F-InKind | 98.77 | 2026-01-05 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | 2025-12-31 | F-InKind | 98.77 | 2026-01-05 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-12-31 | A-Award | 0 | 2026-01-05 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-12-31 | A-Award | 0 | 2026-01-05 |
| Tray Thomas | officer: Principal Accounting Officer | 2025-12-19 | M-Exempt | 95.76 | 2025-12-22 |
| Tray Thomas | officer: Principal Accounting Officer | 2025-12-19 | M-Exempt | 95.76 | 2025-12-22 |
| Tray Thomas | officer: Principal Accounting Officer | 2025-12-18 | S-Sale | 98.25 | 2025-12-22 |
| Tray Thomas | officer: Principal Accounting Officer | 2025-12-19 | S-Sale | 100 | 2025-12-22 |
| Tray Thomas | officer: Principal Accounting Officer | 2025-12-19 | M-Exempt | 95.76 | 2025-12-22 |
| Tray Thomas | officer: Principal Accounting Officer | 2025-12-19 | M-Exempt | 95.76 | 2025-12-22 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | 2025-12-16 | S-Sale | 97.42 | 2025-12-18 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | 2025-12-16 | S-Sale | 97.29 | 2025-12-18 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | 2025-12-17 | S-Sale | 97.26 | 2025-12-18 |
| Mayes Patrick A | officer: EVP & Chief Scientific Officer | 2025-12-10 | S-Sale | 95.58 | 2025-12-12 |
| Mayes Patrick A | officer: EVP & Chief Scientific Officer | 2025-12-11 | S-Sale | 94.94 | 2025-12-12 |
| Hoppenot Herve | director | 2025-12-08 | F-InKind | 96.7 | 2025-12-10 |
| Stein Steven H | officer: EVP & Chief Medical Officer | 2025-12-01 | S-Sale | 102.96 | 2025-12-03 |
| Stein Steven H | officer: EVP & Chief Medical Officer | 2025-12-01 | F-InKind | 102.04 | 2025-12-03 |
| Stein Steven H | officer: EVP & Chief Medical Officer | 2025-12-02 | S-Sale | 102.51 | 2025-12-03 |